Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.07 -0.01 (-0.48%)
As of: Oct 23, 2026 · 3:59 PM EDT

Ernexa Therapeutics (ERNA) Net of Acquisitions & Divestments (2021)

Updated

Analysis

Ernexa Therapeutics (ERNA) Net of Acquisitions & Divestments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.15 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 39.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -11.21 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Ernexa Therapeutics 2.46 Mn -16.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 119,000.00
API Access

Ernexa Therapeutics Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=ERNA&period=max&api_key=YOUR_API_KEY